Processing

Please wait...

Settings

Settings

1. WO2020005215 - IMPROVEMENT OF BLOOD MICROPERFUSION TO SKIN BY SHILAJIT

Publication Number WO/2020/005215
Publication Date 02.01.2020
International Application No. PCT/US2018/039593
International Filing Date 26.06.2018
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35
Medicinal preparations containing material or reaction products thereof with undetermined constitution
02
from inanimate materials
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
35
having six-membered rings with one oxygen as the only ring hetero atom
352
condensed with carbocyclic rings, e.g. cannabinols, methantheline
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
535
having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
5375
1,4-Oxazines, e.g. morpholine
538
ortho- or peri-condensed with carbocyclic ring systems
A61K 35/02 (2015.01)
A61K 31/352 (2006.01)
A61K 31/538 (2006.01)
CPC
A61K 31/352
A61K 35/02
Applicants
  • NATREON, INC. [US/US]; 2-D Janine Place New Brunswick, NJ 08901, US
Inventors
  • SEN, Chandan, K.; US
  • KALIDINDI, Sanyasi; US
Agents
  • CARRERA, George, M., Jr.; US
  • KRIT, Jonathan, J.; US
  • CWIK, Joseph, E.; US
  • SUSSMAN, Adam; US
  • BATZER, Brent, A.; US
Priority Data
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) IMPROVEMENT OF BLOOD MICROPERFUSION TO SKIN BY SHILAJIT
(FR) AMÉLIORATION DE LA MICROPERFUSION SANGUINE À TRAVERS LA PEAU PAR SHILAJIT
Abstract
(EN)
Methods of using Shilajit or its individual components, or a combination of two or more of these components, to improve skin microperfusion, to upregulate ECM related genes in the skin, to increase endothelial cell migration and growth of blood vessels, and thus to improve skin health are presented herein.
(FR)
L'Invention concerne des méthodes d'utilisation de Shilajit ou de ses constituants individuels, ou d'une association d'au moins deux de ces constituants, pour améliorer une microperfusion à travers la peau, pour réguler à la hausse les gènes liés à la MEC dans la peau, pour accroître la migration et la croissance des cellules endothéliales des vaisseaux sanguins, et ainsi améliorer la santé de la peau.
Latest bibliographic data on file with the International Bureau